A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTIPLE-DOSE PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BMS-986263 IN ADULTS WITH COMPENSATED CIRRHOSIS FROM NONALCOHOLIC STEATOHEPATITIS (NASH)

Registry ID
IM025017
Source registry
HEALTH_CANADA
Status
Closed
Phase
PHASE2
Study type
INTERVENTIONAL
Sponsor
BRISTOL-MYERS SQUIBB CANADA
Start date
2023-02-23
Completion date
2024-10-03
Last update
2021-03-10

Conditions

Related clinical trials

View on source registry